Neutralization of CD40 and/or IL-21 reduced antibody production more effectively in pSS than in healthy controls in vitro; thus, the interruption of T and B-cell collaboration may be a potential therapeutic approach for down-regulating pathological humoral immunity in pSS. This evidence concerns the gene IL21 and peeling skin syndrome.